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Metabolic disturbances are well-known, but sometimes neglected immediate conse-
quences or late sequelae following urinary diversion (UD) using bowel segments.Whereas
subclinical disturbances appear to be quite common, clinically relevant metabolic complica-
tions, however, are rare. Exclusion of bowel segments for UD results in loss of absorptive
surface for its physiological function. Previous studies demonstrated that at least some of
the absorptive and secreting properties of the bowel are preserved when exposed to urine.
For each bowel segment typical consequences and complications have been reported.The
use of ileal and/or colonic segmentsmay result in hyperchloremicmetabolic acidosis, which
can be prevented if prophylactic treatment with alkali supplementation is started early.The
resection of ileal segments may be responsible for malabsorption of vitamin B12 and bile
acids with subsequent neurological and hematological late sequelae as well as potential
worsening of the patient’s bowel habits. Hence, careful patient and procedure selection,
meticulous long-term follow-up, and prophylactic treatment of subclinical acidosis is of
paramount importance in the prevention of true metabolic complications.
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METABOLIC ALTERATIONS AND COMPLICATIONS
Whenever bowel segments are excluded from the gastrointesti-
nal tract for urinary diversion (UD), the absorptive surface of
the respective segment is irreversibly lost for physiological bowel
function. Functional bowel loss affects the absorption of nutrients
and water from small and large bowel (1–5). Some of the absorp-
tive and secreting properties of bowel are preserved if exposed to
urine, as clearly demonstrated by previous studies (3, 5). Typical
metabolic consequences and complications have been reported for
each bowel segment. They have been demonstrated to occur more
frequently in patients having undergone continent UD due to the
use of longer intestinal segments compared with shorter segments
required for ileal and colonic conduits (2, 5, 6). Metabolic dis-
turbances involve mainly the electrolytes, loss of bile acids, and
malabsorption of vitamin B12, the extent of which depends on the
length and type of bowel segment used, the duration of the stor-
age interval, and the concentration of the urinary constituents the
bowel is exposed to, the degree of atrophy of the bowel mucosa,
and, importantly, the patient’s renal and liver function. Further
factors include patient age, status post irradiation or chemother-
apy and primary or secondary diseases, which may promote or
give rise to subsequent metabolic complications (3).
ELECTROLYTES
One of the most common metabolic consequences and com-
plications are electrolyte imbalances. Whereas the majority of
electrolytes freely traverse the intestinal segments across the apical
surface of intestinal cells (transcellular movement), there is also
some electrolyte movement between the cell borders (paracellular
transport) (7).
GASTRIC SEGMENTS
Hypochloremic hypokalemic metabolic alkalosis may occur when
gastric segments are used for UD; this has been reported to be
life-threatening in some cases (8). The intestinal hormone gastrin
seems to play a major role in this syndrome as with higher gastrin
levels metabolic alkalosis becomes more severe (9).
JEJUNUM
The use of jejunum may entail hyponatremia, hypochloremia,
hyperkalemia, azotemia, and acidosis paralleled by excessive loss
of sodium chloride and by free water, which in turn can result in
dehydration with subsequent hypovolemia and increased renin
and aldosterone levels (6, 10). The more proximal and the
longer the jejunal segment used, the more clinically relevant these
disturbances may present as (11, 12).
ILEAL AND COLONIC SEGMENTS
Exclusion of ileal and colonic bowel segments may result in hyper-
chloremic metabolic acidosis. During the past 60 years, the under-
lying pathophysiological mechanisms have been the subject of
intensive studies (7). Beside a complex interplay of various factors,
ammonium ions (NH+4 ) are believed to play a major role. When
colonic or ileal segments are exposed to urine, ionized ammo-
nium and chloride (Cl−) are reabsorbed by the mucosa (13–15).
Mediated by a sodium–hydrogen antiport, ammonium absorp-
tion occurs in exchange of sodium (Na+) (16). The exchange of
ammonium (NH+4 ) for a proton (H+) in turn is coupled with
the exchange of bicarbonate for chloride (Cl−) (6). Furthermore,
ionized ammonium may be also absorbed into the blood through
potassium (K+) channels (17), resulting in potential bicarbonate
and potassium losses.
ACIDOSIS IN RELATION TO THE DIFFERENT TYPES OF
URINARY DIVERSION
In patients having undergone ileal conduit diversion, mild to
moderate acidosis can be expected in up to 15%. Up to 10% of
patients will require antiacidotic treatment (18–20). In patients
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with a continent UD, the contact time of urine is markedly longer
and the exposed surface of bowel mucosa is much larger. As a
consequence, this can lead to a higher incidence of electrolyte dis-
turbances. Therefore, metabolic acidosis has been reported in up
to 50% of patients (7, 21). An elevated serum chloride concentra-
tion is associated with a decreased base excess (2, 7, 22). Treatment
of hyperchloremic acidosis consists of administration of alkalizing
agents. Prophylactic alkali substitution should be commenced at
a base excess below −2.5 mmol/L, with the aim of avoiding the
long-term complications of clinically evident acidosis (23).
BONE DENSITY
Incorporation of ileal and/or colonic segments into the urinary
tract can lead to chronic acidosis, which may play a major role in
a decrease of bone mineral density following UD. The occurrence
of rickets in children has been previously reported, but constitutes
an extremely rare complication in practice. Similarly, osteomalacia
and osteoporosis may develop in adults. However, the definition
of osteoporosis in younger adults is not clearly established. At least
three possible mechanisms underlying osteoporosis after UD have
been described. Bone carbonate has the potential to buffer chronic
acidosis in exchange for hydrogen ions with subsequent release of
calcium into the circulation. Calcium is then cleared by the kid-
neys (24–26). Importantly, renal tubule calcium reabsorption is
directly inhibited by sulfate (7, 27), with chronic acidosis being a
cause for increased intestinal sulfate absorption. Furthermore, aci-
dosis has been reported to activate osteoclasts resulting in further
bone resorption (28). Finally, impaired intestinal absorption of
both calcium and vitamin D may additionally develop in response
to ileal resection (2).
With all these different pathophysiological pathways in mind,
one could hypothesize that a substantial proportion of patients fol-
lowing UD using bowel segments will suffer from decreased bone
mineralization. Indeed, there are some early reports of osteoma-
lacia after ureterosigmoidostomy (29–31), ureterosigmoidostomy
(32), Kock pouch (33), and segmental ileal ureteric replacement
(34). Interestingly, remineralization of the bones was shown to
be possible by correction of acidosis in two early reports (35, 36).
Both animal and clinical studies have demonstrated, that the meta-
bolic disturbances are not as severe as commonly assumed, and,
even more importantly, that they could be prevented with the
proviso that prophylactic treatment is initiated early (1, 26, 37–
39). In clinical practice, mild chronic acidosis was shown to be
preventable, if a base deficit of more than −2.5 mmol/L was cor-
rected early. In these patients, no signs of bone demineralization
were observed (40). If osteomalacia occurs, correction of acidosis,
dietary supplements with calcium, vitamin D and, in severe cases,
bisphosphonates are recommended (35, 36, 41, 42).
GROWTH RETARDATION
In 1992, Mundy and Nurse as well as Wagstaff et al. found
delayed linear growth in some children after UD (43, 44). The
Baltimore group in the States observed decreased linear growth
in patients with bladder exstrophy who had undergone intesti-
nal augmentation, as opposed to those without augmentation
(45). In a frequently cited long-term study of 93 patients with
status post various treatment modalities for meningomyelocele
(colonic conduit n= 2, ileal conduit n= 28, conservative treat-
ment n= 63) it was shown that those with UD had a decreased
linear growth; the rate of complications following orthopedic
surgery was 17% compared to 3% in the conservative group (46).
Recurrent pyelonephritis occurred in 60% of the patients with a
conduit as opposed to “only” 21% in the conservative group; like-
wise, deterioration of the upper urinary tract was observed in 57
and 8%, respectively. All these factors may compromise renal func-
tion and thereby decrease the ability of the kidneys to counteract
acidosis, which, as already stated above, has a negative impact
on bone mineral density. Twenty percent of the patients with
a conduit diversion had intermittent metabolic acidosis. At that
time, the incidence of complications following orthopedic proce-
dures in patients with meningomyelocele ranged between 16 and
29% (47, 48).
It is of note, however, that conclusions of all of the above ret-
rospective studies are limited by methodological shortcomings.
For instance, it has been clearly demonstrated that a reduced
bone mineral density is markedly more common in children with
myelomeningocele than in others undergoing UD (49). In sup-
port of this, another recently published study provided compelling
evidence that there is a significant correlation between low-bone
density and wheelchair-dependence in children. Moreover, an
association between reduced bone density and higher neurolog-
ical deficit was suggested (50). Gerharz et al. emphasized, that
it is worth to take a second look at the linear growth of patients
who had undergone enterocystoplasty in childhood. In their study,
the initial series by Wagstaff et al. were incorporated (43, 51).
Eighty-five percent of patients remained on the same or reached a
higher centile after surgery; only 15% were in a lower position, and
clinically relevant growth retardation was recognized in only four
patients. All these patients underwent a complete endocrinolog-
ical evaluation demonstrating that enterocystoplasty was not the
underlying cause of growth retardation in a single case. Therefore,
it seems very unlikely that the post-operative loss of the changes in
position on the growth curve is a consequence of the UD. Rather,
it seems to be more likely a non-specific phenomenon that should
be considered in any clinical population of similar size and age
distribution after the same length of time (51).
VITAMIN B12
Vitamin B12 (cobalamin) cannot be synthesized by mammalians
and must be ingested from food. It plays an important role in DNA
synthesis and neurological function. The acidic environment in the
stomach facilitates the uncoupling of vitamin B12 from food. The
parietal cells in the stomach secrete intrinsic factor, which binds
to vitamin B12 in the duodenum. In the ileum, the vitamin B12-
intrinsic factor complex helps absorb vitamin B12 (52). Moreover,
the so-called cubilin receptor, which is found in the entire ileum
and not only in the terminal ileum, has also a physiological role
in the absorption of vitamin B12 (53–55). Additionally, there is
some evidence of the existence of an alternative system, which is
obviously independent of the intrinsic factor or the terminal ileum
and about 1% of orally administered vitamin B12 is absorbed by
an additional, yet unknown, pathway (52, 56, 57). Collectively,
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current knowledge suggests that the terminal ileum is not the only
site of vitamin B12 absorption (56–61). A normal Western-style
diet contains approximately 5–15µg of vitamin B12 per day; how-
ever, the daily requirement amounts to only 1–2µg. Furthermore,
the large hepatic vitamin B12 depot in humans prevents symptoms
of vitamin B12 deficiency over a period of 2–5 years even in the
presence of severe malabsorption (62). On the other hand, overt
vitamin B12 deficiency may result in megaloblastic macrocytic
anemia, Hunter’s glossitis, and funicular myelosis, an irreversible
degeneration of spinal cord white matter. In most cases, however,
vitamin B12 deficiency can remain completely asymptomatic (63,
64). In adults, resection of more than 60 cm of ileum increases the
risk of development of a vitamin B12 deficiency, as shown by some
earlier studies (65–69). In children, impaired vitamin B12 absorp-
tion was demonstrated following resection of more than 45 cm
of ileum demonstrated impaired vitamin B12 absorption (70),
whereas another study concluded that vitamin B12 absorption in
children normalizes after ileal resection (71).
Other studies reported low vitamin B12 levels in adults in whom
ileal segments had been used for UD. This was particularly evi-
dent if longer segments of ileum were used (22, 72–81). However,
the length of excluded ileum is not the only contributing factor
(82): radiation therapy (83, 84), patient age (85–87), as well as
administration of omeprazole (88) may all cause malabsorption
of vitamin B12.
In children, no decrease in vitamin B12 levels was observed
following bladder augmentation and substitution using ileal seg-
ments inmost cases after a follow-up period of up to 8 years (89).
By contrast, Rosenbaum et al. demonstrated an increasing risk of
vitamin B12 deficiency after the seventh post-operative year when
ileal segments had been used for bladder augmentation. In their
study, 6 out of 29 patients had low vitamin B12 levels (90). In a
further study in which the ileocecal segment had been used, a slow
decrease of serum vitamin B12 level was detected in more than
60% of patients; 8% underwent substitution after completion of a
follow-up of 23 years (91).
In up to 35% of adult patients, substitution therapy is initiated
following UD with ileal segments, such as ileal neobladder or ileo-
cecal pouch (22, 74, 76, 77, 79). It is of note, however, that there
are only single case reports of a total of five patients with clinical
symptoms (one with neurological symptoms) seemingly related
to vitamin B12 deficiency (72, 76, 79).
There are some controversies about the normal levels of vita-
min B12 and the impact of age on requirements. A serum vitamin
B12 level <100 ng/L is considered pathological, and some authors
regard a range between 100 and 200 ng/L as borderline, whereas
others recommend substitution of vitamin B12 if the serum level
is below 200 ng/L (52, 64, 85, 92). It should be noted, that there is
wide variation in vitamin B12 serum levels both in adults and chil-
dren. In children, however, supplementation should be considered
if serum levels drop below 200 ng/L, to be on the safe side (90, 91).
Serum vitamin B12 levels should be checked for annually starting
at year five following UD.
With regard to the substitution of vitamin B12 in patients with
cobalamin deficiency, a randomized study provided evidence that
oral therapy (2 mg per day) is as effective as parenteral application
(1 mg intramuscularly) (57).
BOWEL DYSFUNCTION
Chologenic diarrhea due to the loss of bile acids via the large bowel
is one potential source of bowel dysfunction following UD using
bowel segments. The pool of bile acids amount to around 2–4 g
and circulates 5–10 times per day (referred to as “enterohepatic
circulation”) (93). In the ileum, active reabsorption of conjugated
bile acids involves a Na+-coupled co-transport system (94), and
most of the conjugated bile acids are absorbed in the ileum (95).
However, alongside active transport, the enterohepatic circulation
includes also passive absorption of deconjugated bile acids from
the jejunum and ileum. Under the influence of bacterial enzymes
in the colon, deconjugation, 7α-dehydroxylation, and dehydro-
genation of the conjugated bile acids occur (96) and only 0.2–0.4 g
are lost through fecal excretion. This amount is normally synthe-
sized by the liver. Therefore, the pool of bile acids remains by and
large constant over time (97).
Resection of longer ileal segments may entail malabsorption of
bile acids with subsequent excess transition of bile acids, water,
and sodium into the colon. This can result in chologenic (bile
acid) diarrhea (98). Multiple mechanisms of bile acid diarrhea are
known (96, 99–102), but it remains still unclear which is the most
important one (103). An increase of hepatic bile acid synthesis
compensates for the loss. However, with increasing length of ileal
resection, depletion of the bile acid pool can occur, resulting in
malabsorption of fatty acids, which in turn can cause steatorrhea
(104, 105). If the ileocecal valve is resected during UD, colonic
organisms (e.g., Bacteroides ssp.) can enter the ileum, which is
usually free of bacterial colonization. These microorganisms cleave
bile acids from their conjungates. Free bile acids emulsify fat to a
very low extent. As a consequence, micellar formation is reduced
resulting in decreased fat absorption. This is a further cause of
steatorrhea (106–108). Moreover, exclusion of the ileocecal valve
decreases the intestinal transit time (0.8–2.5 h) (109) and thus,may
increase stool frequency. Reconstruction of the ileocecal valve was
previously recommended in patients with risk factors for develop-
ing post-operative diarrhea (110). However, in a long-term study
using matched pairs, no difference was found between patients
with and those without reconstruction of the ileocecal valve (111).
In the literature, only few reports have focused on bowel dys-
function after UD. In patients having undergone ileal or colonic
conduit diversion, an increase of stool frequency was reported in
4–33%, following bladder augmentation or substitution in 7–59%,
and after continent cutaneous diversion in 3–23% (112–119). In
this context, it is noteworthy, however, that stool incontinence has
been reported as surprisingly common in epidemiological stud-
ies, with an estimated prevalence of up to 20% depending on age,
gender, and population (120, 121).
In patients with chologenic diarrhea, the principle of treat-
ment is a reduction of bile acids in the colon. It has been known
for a long time that cholestyramine effectively binds bile acids and
reduces stool frequency after ileal resection (122). Patients with
a long-term use of this substance are at risk of interference of
cholestyramine with the absorption of fat-soluble vitamins such
as vit. A, D, and K (123, 124). Therefore, vitamin levels should be
checked. In patients with status post ileocecal pouch, no changes
of the above vitamins were observed (125). Patients suffering from
steatorrhea due to UD should be recommended a low fat diet. In
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patients with more severe bile acid malabsorption, cholylsarco-
sine (a bile acid analog) can be used for replacement (126) and
substitution of fat-soluble vitamins may become necessary. Inter-
estingly, there are only two reports on complications due to the
lack of fat-soluble vitamins after bowel resection in adults (127,
128), whereas there are no reports thus far in patients after UD
(22, 76).
CONCLUSION
Metabolic consequences and disturbances are quite common in
patients after UD using intestinal segments. However, careful
patient selection for various types of UD, prophylactic substitution
therapy (alkali supplementation, vitamin B12), early intervention
in case of overt clinical symptoms, and life-long follow up, can
avert or successfully treat major clinical problems in the majority
of cases.
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